Q1 2023 Holdings
Filed 2023-05-15 | 81 holdings | $598.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $75.1M | 420,900 | 12.5% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $30.7M | 75,000 | 5.1% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $28.8M | 529,515 | 4.8% |
| Nice LTD(NSY) | SPONSORED ADR | 653656108 | $26.4M | 115,482 | 4.4% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $19.8M | 285,060 | 3.3% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $18.6M | 119,831 | 3.1% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $18.0M | 2,039,500 | 3.0% |
| Teva Pharmaceutical Inds LTD(TEVA)Call | SPONSORED ADS | 881624209 | $18.0M | 2,037,000 | 3.0% |
| Microsoft Corp(MSFT) | COM | 594918104 | $15.7M | 54,623 | 2.6% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $14.4M | 683,061 | 2.4% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $12.8M | 120,600 | 2.1% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $11.4M | 71,540 | 1.9% |
| Enphase Energy Inc | NOTE 3/0 | 29355AAK3 | $11.2M | 10,725,000 | 1.9% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $10.9M | 31,690 | 1.8% |
| Nutrien LTD(NTR) | COM | 67077M108 | $10.7M | 145,466 | 1.8% |
| Inozyme Pharma Inc | COM | 45790W108 | $10.2M | 1,781,858 | 1.7% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $10.0M | 63,000 | 1.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $9.3M | 33,516 | 1.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $9.3M | 561,983 | 1.6% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $8.8M | 85,680 | 1.5% |
| Invesco QQQ TR(QQQ) | UNIT SER 1 | 46090E103 | $8.5M | 26,353 | 1.4% |
| Springworks Therapeutics Inc | COM | 85205L107 | $8.2M | 317,625 | 1.4% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $7.7M | 159,100 | 1.3% |
| Enlight Renewable Energy LTD(ENLT) | SHS | M4056D110 | $7.6M | 450,864 | 1.3% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $7.4M | 603,287 | 1.2% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $7.4M | 183,696 | 1.2% |
| Jasper Therapeutics Inc | COM | 471871103 | $7.3M | 4,044,008 | 1.2% |
| Point Biopharma Global Inc | COM | 730541109 | $6.9M | 952,642 | 1.2% |
| Camtek LTD(CAMT) | ORD | M20791105 | $6.8M | 239,494 | 1.1% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $6.5M | 155,000 | 1.1% |
| Merus N V | COM | N5749R100 | $6.2M | 336,993 | 1.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $6.1M | 44,000 | 1.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $5.9M | 1,888,228 | 1.0% |
| Select Sector Spdr TR(XLI)Put | SBI INT-INDS | 81369Y704 | $5.8M | 57,700 | 1.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $5.8M | 799,860 | 1.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $5.7M | 140,000 | 1.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $5.6M | 231,591 | 0.9% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $5.6M | 421,018 | 0.9% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $5.5M | 60,000 | 0.9% |
| Immatics N.v(IMTX) | SHS | N44445109 | $5.4M | 780,852 | 0.9% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $5.3M | 339,000 | 0.9% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $5.2M | 167,488 | 0.9% |
| Perion Network LTD(PERI) | SHS NEW | M78673114 | $5.1M | 130,000 | 0.9% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $4.8M | 450,283 | 0.8% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $4.8M | 1,283,537 | 0.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $4.7M | 220,013 | 0.8% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $4.6M | 19,000 | 0.8% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $4.4M | 2,360,580 | 0.7% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $4.2M | 187,500 | 0.7% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $4.0M | 236,000 | 0.7% |